An enzyme-responsive Gp1a-hydrogel for skin wound healing

Area of Science:

• Pharmacology
• Biomaterials Science
• Dermatology

Background:

• Optimizing skin wound healing with reduced scarring is a significant clinical goal.
• Cannabinoid receptor 2 (CB2) agonists, like Gp1a, show promise in modulating inflammatory and fibrotic processes.
• Systemic administration of Gp1a lacks precision for localized skin treatments.

Purpose of the Study:

• To develop and evaluate a novel topical formulation, Gp1a-gel, for enhanced skin wound healing.
• To assess the efficacy of Gp1a-gel in a mouse skin excision wound model.
• To investigate the sustained release and local effects of Gp1a from a triglycerol monostearate (Tm) hydrogel.

Main Methods:

• Preparation of Gp1a-gel using triglycerol monostearate (Tm) hydrogel.
• Administration of Gp1a-gel to mouse skin excision wounds.
• Assessment of CB2 receptor expression, inflammation, fibrogenesis, re-epithelialization, and wound closure rates.

Main Results:

• Gp1a-gel demonstrated sustained CB2 receptor upregulation for at least 8 days.
• The formulation significantly reduced local inflammation and fibrogenesis.
• Gp1a-gel promoted accelerated wound enclosure and enhanced re-epithelialization, leading to improved healing.

Conclusions:

• Gp1a-gel is an effective topical formulation for promoting skin wound healing.
• The localized delivery of Gp1a via Tm hydrogel offers a precise and potentially superior therapeutic strategy.
• Gp1a-gel represents a promising new approach for treating skin wounds, minimizing scarring and improving recovery.